| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 2
| Issue : 1 | Page : 5-7 |
|
|
Chloroquine/hydroxychloroquine in the treatment and prophylaxis of COVID-19 disease
Deepthi Nair
Department of Microbiology, Al-Amiri Hospital, Kuwait City, Kuwait
Correspondence Address:
Dr. Deepthi Nair
Department of Microbiology, Al-Amiri Hospital, Kuwait City
Kuwait
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ACCJ.ACCJ_5_20
|
|
|
COVID-19 is a zoonotic viral infection caused by severe acute respiratory syndrome coronavirus-2. Although the management of COVID-19 infection is mainly supportive, the arena of infective therapy now also includes drugs such as chloroquine and its substitute, hydroxychloroquine, which are believed to have antiviral properties in addition to their antimalarial and immunomodulating effects. The objective of this review article is to focus on the antiviral effect of chloroquine/hydroxychloroquine in the treatment and prophylaxis of COVID-19 disease.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
